Klaus Vuorinen
About
In The Last Decade
Klaus Vuorinen
10 papers receiving 372 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 172
- Pathology and Forensic Medicine 134
- Cardiology and Cardiovascular Medicine 120
- Emergency Medicine 49
- Radiology, Nuclear Medicine and Imaging 39
Countries citing papers authored by Klaus Vuorinen
This map shows the geographic impact of Klaus Vuorinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Vuorinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Vuorinen more than expected).
Fields of papers citing papers by Klaus Vuorinen
This network shows the impact of papers produced by Klaus Vuorinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Vuorinen. The network helps show where Klaus Vuorinen may publish in the future.
Co-authorship network of co-authors of Klaus Vuorinen
This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Vuorinen. A scholar is included among the top collaborators of Klaus Vuorinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Vuorinen. Klaus Vuorinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 31 | |
| 2 | Aminoterminal propeptide of the alpha1-homotrimer variant of human type I procollagen (hotPINP) in malignant pleural effusion. | 5 |
| 3 | 18 | |
| 4 | Role of cellular energetics in ischemia-reperfusion and ischemic preconditioning of myocardium. | 24 |
| 5 | 22 | |
| 6 | Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP. | 39 |
| 7 | 20 | |
| 8 | 114 | |
| 9 | 111 | |
| 10 | 13 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.